John C. Lechleiter

2014

In 2014, John C. Lechleiter earned a total compensation of $14.5M as Chairman, President, and Chief Executive Officer at Lilly Eli & Co, a 29% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$4,356,142
Non-Equity Incentive Plan$1,785,000
Salary$1,500,000
Stock Awards$6,750,000
Other$90,000
Total$14,481,142

Lechleiter received $6.8M in stock awards, accounting for 47% of the total pay in 2014.

Lechleiter also received $4.4M of change in pension value and nonqualified deferred compensation earnings, $1.8M in non-equity incentive plan, $1.5M in salary and $90K in other compensation.

Rankings

In 2014, John C. Lechleiter's compensation ranked 255th out of 13,032 executives tracked by ExecPay. In other words, Lechleiter earned more than 98.0% of executives.

ClassificationRankingPercentile
All
255
out of 13,032
98th
Division
Manufacturing
99
out of 4,967
98th
Major group
Chemicals And Allied Products
37
out of 1,690
98th
Industry group
Drugs
29
out of 1,369
98th
Industry
Pharmaceutical Preparations
27
out of 1,042
97th
Source: SEC filing on March 20, 2017.

Lechleiter's colleagues

We found four more compensation records of executives who worked with John C. Lechleiter at Lilly Eli & Co in 2014.

2014

Derica Rice

Lilly Eli & Co

Chief Financial Officer

2014

Jan Lundberg

Lilly Eli & Co

Executive Vice President, Science and Technology, and President, Lilly Research Laboratories

2014

Michael Harrington

Lilly Eli & Co

General Counsel

2014

Enrique Conterno

Lilly Eli & Co

Senior Vice President and President, Lilly Diabetes

You may also like